Key facts
- Notable investors include Zinc.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Avanc
- ·The full record, as it builds
Funding rounds
No funding rounds for Avanc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Avanc
Developer of biosensing technology intended to provide real-time detection of biological risks. The company's platform uses modular sensor arrays and advanced signal processing, enabling users to monitor antimicrobial resistance and harmful algal blooms with early visibility.
- Sector
- Healthcare
- HQ
- Bristol, United Kingdom
- Founded
- 2025
- Employees
- 2
- Website
- avanc.bio/
- Ownership
- Privately Held (backing)
Avanc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Avanc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Avanc in its N-PORT filings yet. We sweep new filings monthly.